EUVIMEDEUVIMED entdecken
Crossref

What we know from Lp(a)HORIZON and what remains unknown

Ahmed Abdelaziz, Leandro Slipczuk, Deepak L Bhatt

Progress in Cardiovascular Diseases · 2026-11

DOI: 10.1016/j.pcad.2026.11.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Progress in Cardiovascular Diseases, 2026-11. Verfasst von Ahmed Abdelaziz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Al-Azhar University, Cairo, Egypt. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Cardiovascular risk factorsClinical trialsLp(a) loweringPelacarsen

Autor:innen und Institutionen

  • Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
  • Division of Cardiology, Montefiore Health System, Albert Einstein College of Medicine, New York, NY, USA.
  • Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: DLBhattMD@post.Harvard.edu.

Zitieren

APA

Abdelaziz, A., Slipczuk, L., & Bhatt, D. L. (2026). What we know from Lp(a)HORIZON and what remains unknown. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2026.11.005

Vancouver

Abdelaziz A, Slipczuk L, Bhatt DL. What we know from Lp(a)HORIZON and what remains unknown. Progress in Cardiovascular Diseases. 2026. doi:10.1016/j.pcad.2026.11.005

BibTeX
@article{Abdelaziz2026,
  author = {Abdelaziz, Ahmed and Slipczuk, Leandro and Bhatt, Deepak L},
  title = {What we know from Lp(a)HORIZON and what remains unknown},
  journal = {Progress in Cardiovascular Diseases},
  year = {2026},
  doi = {10.1016/j.pcad.2026.11.005}
}
Kostenlos starten →